Antimicrobial Activity of Essential Oils against Helicobacter pylori

作者: Tomoyuki Ohno , Masakazu Kita , Yoshio Yamaoka , Shigeyoshi Imamura , Toshiro Yamamoto

DOI: 10.1046/J.1523-5378.2003.00146.X

关键词:

摘要: Background.Helicobacter pylori is an important pathogen responsible for gastroduodenal diseases in humans. Although the eradication of H. pylori using antibiotics often improves diseases, resistance to emerging. Materials and Methods. The antimicrobial effect essential oils development were evaluated vitro vivo. Results. Thirteen used this study completely inhibited growth at a concentration 0.1% (v/v). Cymbopogon citratus (lemongrass) Lippia citriodora (lemon verbena) bactericidal against 0.01% pH 4.0 5.0. Resistance lemongrass did not develop even after 10 sequential passages, whereas clarithromycin developed under same conditions. In vivo studies, density stomach mice treated with was significantly reduced compared untreated mice. Conclusions. These results demonstrate that are without acquired resistance, suggesting may have potential as new safe agents inclusion anti-H. regimens.

参考文章(29)
Erik A.J. Rauws, Wies Langenberg, Guido N.J. Tytgat, Hendrik J. Houthoff, H.C. Zanen, Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. ,vol. 94, pp. 33- 40 ,(1988) , 10.5555/URI:PII:0016508588906063
Michael S. Osato, Osmotic effect of honey on growth and viability of Helicobacter pylori. Digestive Diseases and Sciences. ,vol. 44, pp. 462- 464 ,(1999) , 10.1023/A:1026676517213
Rie Ohta, Norihiko Yamada, Hisae Kaneko, Keiko Ishikawa, Hiroyuki Fukuda, Tsuchiyoshi Fujino, Atsushi Suzuki, In vitro inhibition of the growth of Helicobacter pylori by oil-macerated garlic constituents. Antimicrobial Agents and Chemotherapy. ,vol. 43, pp. 1811- 1812 ,(1999) , 10.1128/AAC.43.7.1811
Katsuhiro Mabe, Masami Yamada, Itaro Oguni, Tsuneo Takahashi, In Vitro and In Vivo Activities of Tea Catechins against Helicobacter pylori Antimicrobial Agents and Chemotherapy. ,vol. 43, pp. 1788- 1791 ,(1999) , 10.1128/AAC.43.7.1788
J Versalovic, D Shortridge, K Kibler, M V Griffy, J Beyer, R K Flamm, S K Tanaka, D Y Graham, M F Go, Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 477- 480 ,(1996) , 10.1128/AAC.40.2.477
K. A. Hammer, C. F. Carson, T. V. Riley, Antimicrobial activity of essential oils and other plant extracts Journal of Applied Microbiology. ,vol. 86, pp. 985- 990 ,(1999) , 10.1046/J.1365-2672.1999.00780.X
Thomas K.W. Ling, Augustine F.B. Cheng, Joseph J.Y. Sung, Phyllis Y.L. Yiu, Sydney S.C. Chung, An Increase in Helicobacter pylori Strains Resistant to Metronidazole: A Five‐Year Study Helicobacter. ,vol. 1, pp. 57- 61 ,(1996) , 10.1111/J.1523-5378.1996.TB00009.X
A. T. R. Axon, P. Moayyedi, Eradication of Helicobacter pylori: omeprazole in combination with antibiotics. Scandinavian Journal of Gastroenterology. ,vol. 215, pp. 82- 89 ,(1996) , 10.3109/00365529609094542
Takeshi Itoh, Yoshitoki Yanagawa, Masao Shingaki, Masaki Takahashi, Akemi Kai, Makoto Ohashi, Gennichi Hamana, Isolation of Campylobacter pyloridis from Human Gastric Mucosa and Characterization of the Isolates Microbiology and Immunology. ,vol. 31, pp. 603- 614 ,(1987) , 10.1111/J.1348-0421.1987.TB03121.X
Yoshio Yamaoka, Tadashi Kodama, Masakazu Kita, Jiro Imanishi, Kei Kashima, David Y. Graham, Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. ,vol. 3, pp. 241- 253 ,(1998) , 10.1046/J.1523-5378.1998.08056.X